CIK 0000715446
- Non-accelerated filer
- Smaller reporting company
Anixa Biosciences Inc
Sign in to watch- Ticker
- ANIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Oct 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 112622630
- Phone
- +1 408-708-9808
- Business address
- 3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, CA, 95118
- Former names
- ITUS Corp, COPYTELE INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale V.P. - Finance & CFO sold 15,000 shares at $0.52 ($7,800)
- 4 Open-market sale V.P. Finance & C.F.O. sold 10,000 shares at $0.50 ($5,000)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 5 Insider Annual Insider Trading Report
- 4 Grant or award Chief Executive Officer acquired 120,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Executive Officer acquired 100,000 shares (grant or award)
- 4 Grant or award VP - Finance & Chief Fin. Off. acquired 25,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Director acquired 40,000 shares (option exercise)
- 4 Derivatives Options or other derivatives
Page 23 of 24 · 471 filings